What is Velmanase Alfa: Uses, Dosage, Side Effects and More

Velmanase alfa is a specialized enzyme replacement therapy designed to treat alpha-mannosidosis, a rare genetic disorder. This medication works by providing your body with the enzyme it lacks naturally, helping to break down certain sugar molecules that would otherwise build up in your cells.

Alpha-mannosidosis affects fewer than 1 in 500,000 people worldwide, making velmanase alfa what doctors call an "orphan drug." While this condition is uncommon, having an effective treatment available can make a significant difference for those who need it.

What is Velmanase Alfa?

Velmanase alfa is a man-made version of the enzyme alpha-mannosidase that your body naturally produces. In people with alpha-mannosidosis, this enzyme either doesn't work properly or isn't made in sufficient amounts.

The medication is given through an intravenous (IV) infusion, which means it's delivered directly into your bloodstream through a vein. This allows the enzyme to reach all parts of your body where it's needed most effectively.

Think of it as providing your body with the missing tool it needs to properly process certain sugars. Without this enzyme, these sugars accumulate in your cells and can cause various health problems over time.

What is Velmanase Alfa Used For?

Velmanase alfa is specifically approved to treat alpha-mannosidosis in adults and children. This genetic condition causes a buildup of complex sugars called mannose-rich oligosaccharides in your body's cells.

Alpha-mannosidosis can affect multiple parts of your body, including your immune system, bones, muscles, and brain function. The condition often causes intellectual disability, hearing loss, skeletal abnormalities, and frequent infections.

By replacing the missing enzyme, velmanase alfa helps reduce the sugar buildup in your cells. This can help slow the progression of symptoms and may improve some existing problems, though results vary from person to person.

How Does Velmanase Alfa Work?

Velmanase alfa works by substituting for the deficient alpha-mannosidase enzyme in your body. Once infused into your bloodstream, the medication travels to your cells where it begins breaking down the accumulated sugar molecules.

This is considered a strong, targeted therapy because it directly addresses the root cause of alpha-mannosidosis. Unlike treatments that only manage symptoms, enzyme replacement therapy tackles the underlying enzyme deficiency.

The process is gradual and ongoing. Your body continuously produces these complex sugars, so regular infusions are necessary to maintain the enzyme levels needed to process them effectively.

How Should I Take Velmanase Alfa?

Velmanase alfa is always given as an intravenous infusion at a medical facility by trained healthcare professionals. You cannot take this medication at home or by mouth.

The typical dose is 1 mg per kilogram of your body weight, given once weekly. Your infusion will usually take about 50 minutes to complete, though your healthcare team may adjust the speed based on how well you tolerate it.

Before each infusion, your medical team will likely give you medications to help prevent allergic reactions. These might include antihistamines or corticosteroids, which help your body accept the treatment more comfortably.

You don't need to follow any special dietary restrictions before or after your infusion. However, it's important to stay well-hydrated and let your healthcare team know if you're feeling unwell before treatment.

How Long Should I Take Velmanase Alfa For?

Velmanase alfa is typically a lifelong treatment for alpha-mannosidosis. Since this is a genetic condition, your body will continue to lack the necessary enzyme throughout your life.

Your doctor will monitor your response to treatment through regular check-ups and tests. They'll look at various markers to see how well the medication is working and whether any adjustments are needed.

Some people may see improvements in certain symptoms within the first few months of treatment. However, the full benefits of enzyme replacement therapy often take longer to become apparent, sometimes requiring a year or more of consistent treatment.

What Are the Side Effects of Velmanase Alfa?

Like all medications, velmanase alfa can cause side effects, though not everyone experiences them. Most side effects are related to the infusion process itself and tend to be mild to moderate.

Here are the most common side effects you might experience during or shortly after your infusion:

• Headache and fatigue
• Nausea or stomach discomfort
• Fever or chills
• Skin reactions like rash or itching
• Joint or muscle pain
• Dizziness or feeling lightheaded

These reactions often improve as your body gets used to the treatment. Your healthcare team can also adjust your infusion rate or pre-medications to help minimize these effects.

More serious allergic reactions are less common but can occur. These might include difficulty breathing, severe skin reactions, or significant drops in blood pressure. Your medical team is trained to recognize and treat these reactions quickly if they occur.

Some people develop antibodies against the medication over time, which can affect how well it works. Your doctor will monitor for this through regular blood tests and adjust your treatment plan if needed.

Who Should Not Take Velmanase Alfa?

Velmanase alfa is generally safe for most people with alpha-mannosidosis, but there are some situations where extra caution is needed. People with severe allergic reactions to the medication or its ingredients should not receive it.

If you have a history of severe allergic reactions to other enzyme replacement therapies, your doctor will need to weigh the benefits and risks carefully. They might recommend additional pre-medications or closer monitoring during infusions.

People with active, severe infections may need to delay treatment until the infection is under control. Your immune system needs to be stable to handle the infusion safely.

Pregnant or breastfeeding women should discuss the risks and benefits with their healthcare provider. While there's limited data on safety during pregnancy, the medication may still be recommended if the benefits outweigh the potential risks.

Velmanase Alfa Brand Name

Velmanase alfa is marketed under the brand name Lamzede in the United States and Europe. This is the only brand name currently available for this specific enzyme replacement therapy.

The medication is manufactured by Chiesi Farmaceutici and was approved by the FDA in 2018. It's also approved by the European Medicines Agency for use in European countries.

Since alpha-mannosidosis is so rare, Lamzede is classified as an orphan drug, which means it receives special regulatory support to encourage its development and availability.

Velmanase Alfa Alternatives

Currently, there are no other enzyme replacement therapies specifically approved for alpha-mannosidosis. Velmanase alfa is the only medication of its kind available for this condition.

Before velmanase alfa became available, treatment for alpha-mannosidosis was limited to managing symptoms and complications. This might include physical therapy, hearing aids, treatments for infections, or surgery for skeletal problems.

Some experimental treatments are being researched, including gene therapy approaches, but these are still in early stages of development. Your doctor can discuss whether you might be eligible for any clinical trials if you're interested in exploring other options.

Supportive care remains an important part of managing alpha-mannosidosis alongside enzyme replacement therapy. This includes regular monitoring, preventive care, and addressing specific symptoms as they arise.

Is Velmanase Alfa Better Than Other Enzyme Replacement Therapies?

Velmanase alfa cannot be directly compared to other enzyme replacement therapies because it's the only one designed for alpha-mannosidosis. Each enzyme replacement therapy is specific to the particular enzyme deficiency it treats.

However, velmanase alfa follows the same general principles as other successful enzyme replacement therapies used for conditions like Gaucher disease or Fabry disease. These treatments have shown that replacing missing enzymes can effectively slow disease progression and improve quality of life.

The effectiveness of velmanase alfa appears to be similar to other enzyme replacement therapies in terms of safety profile and the types of improvements patients can expect. Most people tolerate it well and see some degree of benefit over time.